Advanced Strategies to Identify and Manage Early Alzheimer's Disease in Clinical Practice
Advanced Strategies to Identify and Manage Early Alzheimer's Disease in Clinical Practice is organized by Prime Education, LLC.
Release Date:March 29, 2023
Expiration Date:March 28, 2024
Description:
Alzheimer's disease is a progressive, neurodegenerative disease that has profound effects on those living with it and those caring for them. As there is no one universal symptom that triggers initial suspicion for Alzheimer's during the earliest stages, it can be challenging for providers to recognize, screen, and diagnose patients. Early diagnosis is critical for the initiation of disease-modifying therapies (DMT), and to help patients and care partners gain support to manage symptoms and share their experiences, preferences, and goals for care.
In addition, patient-provider communication can also play a vital role in care planning as the disease progresses and needs change. Therefore, it is important that providers have the confidence in distinguishing Alzheimer's disease versus normal aging and other neurocognitive disorders (NCDs), the most up to date knowledge on available therapies, the ability to overcome the systemic barriers to early diagnosis, and strategies to engage patients and care partners in shared decision-making to optimize care.
Download the Point-of-Care Alzheimer's Disease Screening and Assessment Checklist now for succinct, evidence-based information on patient risk factors, signs and symptoms of mild cognitive impairment and early Alzheimer's disease, recommended screening tools for primary care, and suggestions for when to refer patients to additional care.
Agenda:
• Importance of Early Recognition of AD: Detecting the Key Risk Factors, Signs, and Symptoms
• Practical Strategies to Screen and Evaluate for AD in Primary Care, and Coordinating Timely Referrals
• Real-World Patient Insights to Support Effective Communication About the Diagnosis and Management of AD
• Emerging Evidence for Current and Novel Disease Modifying Therapies in AD
Learning Objectives:
• Differentiate signs and symptoms of MIC/early AD from those associated with natural aging
• Incorporate evidence-based strategies and tools for screening and assessing for AD in routine clinical practice
• Assess the latest clinical trial data for current and emerging disease-modifying therapies (DMTs)
• Evaluate real-world insights from patients to bridge gaps in patient-provider communication and shared decision-making